Co-Diagnostics Highlights Vector Smart® Momentum Following New Federal Initiative on Vector-Borne Disease
PR Newswire•07/10/2026•09:00 ET
0
Key Highlights
- ➤Executive Order 14433 directs HHS to pursue rapid diagnostics R&D programs within 90 days
- ➤Vector Smart serves 40 customers across 21 U.S. states
- ➤September 2026 overseas U.S. Air Force order marked Vector Smart’s first international deployment
- ➤New full laboratory installations completed in Florida and Indiana
- ➤Independent state public health laboratory evaluated Vector Smart’s VZDC assay
Expert Statements
Dwight Egan, Chief Executive Officer of Co-Diagnostics
“This new Executive Order reinforces the growing importance of rapid, decentralized detection as part of a broader national strategy to address vector-borne disease”
Dwight Egan, Chief Executive Officer of Co-Diagnostics
“Vector Smart was designed to address that challenge by enabling rapid, decentralized molecular surveillance of mosquito-borne pathogens.”
Dwight Egan, Chief Executive Officer of Co-Diagnostics
“We have built a commercial platform that enables mosquito control programs to bring molecular testing in house, generate actionable results locally and strengthen surveillance in the communities they serve.”
Dwight Egan, Chief Executive Officer of Co-Diagnostics
“With a growing customer base, independent validation and our first U.S. Air Force deployment, we believe Co-Diagnostics is well positioned to contribute as this federal initiative moves toward implementation.”
Co-Diagnostics Highlights Vector Smart® Momentum Following New Federal Initiative on Vector-Borne Disease PR Newswire
New Executive Order prioritizes improved detection and calls for federal R&D programs for rapid diagnostics for mosquito- and tick-borne diseases
Get started
Create a free account to read the full story.